Life Science Biosensor Diagnostics Pty Ltd is 10% Owner at GBS Inc. (GBS). They have made 29 open-market trades across 1 company since 2021, most recently 2022-02-17.
CIK 0001831656
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 29 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GBS | 1,081,804 | $512K |
Shares reported on the most recent Form 4, priced at the 2022-02-22 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 72% | 83% | 86% |
| Avg Move | -5.7% | -4.7% | -31.2% |
| Scored | 29 | 29 | 29 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GBS | SELL | 2022-02-17 | 2022-02-22 | $0.51 | $588K | +89.5% | +105.6% | +36.3% |
| GBS | SELL | 2022-02-16 | 2022-02-18 | $0.63 | $63K | +39.1% | +84.0% | +17.1% |
| GBS | SELL | 2022-02-11 | 2022-02-17 | $0.71 | $213K | +30.5% | +77.9% | +15.3% |
| GBS | SELL | 2022-02-10 | 2022-02-15 | $0.84 | $84K | -31.4% | +10.9% | +2.0% |
| GBS | SELL | 2022-02-09 | 2022-02-11 | $0.86 | $86K | -23.1% | -4.3% | -10.0% |
| GBS | SELL | 2022-02-08 | 2022-02-10 | $0.89 | $89K | -40.3% | -17.3% | -27.6% |
| GBS | SELL | 2022-02-02 | 2022-02-08 | $0.92 | $92K | -42.5% | -31.4% | -37.6% |
| GBS | SELL | 2022-01-31 | 2022-02-03 | $0.90 | $90K | -24.5% | -7.2% | -29.2% |
| GBS | SELL | 2022-01-28 | 2022-02-01 | $0.92 | $92K | -30.1% | -28.8% | -38.4% |
| GBS | SELL | 2022-01-27 | 2022-02-01 | $1.00 | $100K | -30.1% | -28.8% | -38.4% |
| GBS | SELL | 2021-12-17 | 2021-12-21 | $1.49 | $298K | +18.9% | +8.4% | -32.9% |
| GBS | SELL | 2021-11-30 | 2021-12-03 | $1.87 | $468K | -1.2% | -0.6% | -57.6% |
| GBS | SELL | 2021-11-29 | 2021-12-01 | $1.69 | $169K | +0.0% | -18.5% | -60.8% |
| GBS | SELL | 2021-11-24 | 2021-11-29 | $1.64 | $164K | -5.5% | -17.1% | -74.6% |
| GBS | SELL | 2021-11-09 | 2021-11-12 | $2.02 | $606K | -14.9% | -9.7% | -55.7% |
| GBS | SELL | 2021-10-21 | 2021-10-25 | $2.26 | $1.1M | +4.8% | -20.6% | -44.5% |
| GBS | SELL | 2021-10-20 | 2021-10-22 | $2.25 | $109K | +1.9% | -20.7% | -25.5% |
| GBS | SELL | 2021-10-19 | 2021-10-21 | $2.25 | $37K | +2.3% | -23.3% | -25.6% |
| GBS | SELL | 2021-10-14 | 2021-10-18 | $2.18 | $439K | -6.7% | -19.2% | -31.7% |
| GBS | SELL | 2021-10-13 | 2021-10-15 | $2.25 | $264K | -7.6% | -14.7% | -31.3% |
| GBS | SELL | 2021-10-12 | 2021-10-14 | $2.13 | $213K | -2.7% | -12.8% | -28.3% |
| GBS | SELL | 2021-10-08 | 2021-10-12 | $2.30 | $920K | -6.8% | -11.8% | -30.9% |
| GBS | SELL | 2021-09-28 | 2021-09-30 | $2.48 | $496K | -13.5% | -10.3% | -40.5% |
| GBS | SELL | 2021-09-24 | 2021-09-28 | $2.66 | $532K | -6.2% | -11.3% | -32.1% |
| GBS | SELL | 2021-09-23 | 2021-09-27 | $2.77 | $277K | -2.0% | -17.2% | -36.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.